» Articles » PMID: 34565328

Accelerated Hematopoietic Mitotic Aging Measured by DNA Methylation, Blood Cell Lineage, and Parkinson's Disease

Overview
Journal BMC Genomics
Publisher Biomed Central
Specialty Genetics
Date 2021 Sep 27
PMID 34565328
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Aging and inflammation are important components of Parkinson's disease (PD) pathogenesis and both are associated with changes in hematopoiesis and blood cell composition. DNA methylation (DNAm) presents a mechanism to investigate inflammation, aging, and hematopoiesis in PD, using epigenetic mitotic aging and aging clocks. Here, we aimed to define the influence of blood cell lineage on epigenetic mitotic age and then investigate mitotic age acceleration with PD, while considering epigenetic age acceleration biomarkers.

Results: We estimated epigenetic mitotic age using the "epiTOC" epigenetic mitotic clock in 10 different blood cell populations and in a population-based study of PD with whole-blood. Within subject analysis of the flow-sorted purified blood cell types DNAm showed a clear separation of epigenetic mitotic age by cell lineage, with the mitotic age significantly lower in myeloid versus lymphoid cells (p = 2.1e-11). PD status was strongly associated with accelerated epigenetic mitotic aging (AccelEpiTOC) after controlling for cell composition (OR = 2.11, 95 % CI = 1.56, 2.86, p = 1.6e-6). AccelEpiTOC was also positively correlated with extrinsic epigenetic age acceleration, a DNAm aging biomarker related to immune system aging (with cell composition adjustment: R = 0.27, p = 6.5e-14), and both were independently associated with PD. Among PD patients, AccelEpiTOC measured at baseline was also associated with longitudinal motor and cognitive symptom decline.

Conclusions: The current study presents a first look at epigenetic mitotic aging in PD and our findings suggest accelerated hematopoietic cell mitosis, possibly reflecting immune pathway imbalances, in early PD that may also be related to motor and cognitive progression.

Citing Articles

The effect of epigenetic aging on neurodegenerative diseases: a Mendelian randomization study.

Fan J, Liu Q, Liu X, Gong M, Leong I, Tsang Y Front Endocrinol (Lausanne). 2024; 15:1372518.

PMID: 38800486 PMC: 11116635. DOI: 10.3389/fendo.2024.1372518.


Blood-based biological ageing and red cell distribution width are associated with prevalent Parkinson's disease: findings from a large Italian population cohort.

Gialluisi A, Tirozzi A, Costanzo S, De Bartolo M, Belvisi D, Magnacca S Front Endocrinol (Lausanne). 2024; 15:1376545.

PMID: 38660510 PMC: 11041016. DOI: 10.3389/fendo.2024.1376545.


Unveiling the pathophysiology of restless legs syndrome through transcriptome analysis.

Mogavero M, Salemi M, Lanza G, Rinaldi A, Marchese G, Ravo M iScience. 2024; 27(4):109568.

PMID: 38617564 PMC: 11015462. DOI: 10.1016/j.isci.2024.109568.


Assessing causal associations between neurodegenerative diseases and neurological tumors with biological aging: a bidirectional Mendelian randomization study.

Zhang Z, Liu N, Pan X, Zhang C, Yang Y, Li X Front Neurosci. 2024; 17:1321246.

PMID: 38169680 PMC: 10758410. DOI: 10.3389/fnins.2023.1321246.


Integrative Approaches of DNA Methylation Patterns According to Age, Sex and Longitudinal Changes.

Gim J Curr Genomics. 2023; 23(6):385-399.

PMID: 37920553 PMC: 10173416. DOI: 10.2174/1389202924666221207100513.


References
1.
Teschendorff A . A comparison of epigenetic mitotic-like clocks for cancer risk prediction. Genome Med. 2020; 12(1):56. PMC: 7315560. DOI: 10.1186/s13073-020-00752-3. View

2.
Shameli A, Xiao W, Zheng Y, Shyu S, Sumodi J, Meyerson H . A critical role for alpha-synuclein in development and function of T lymphocytes. Immunobiology. 2015; 221(2):333-40. PMC: 4688145. DOI: 10.1016/j.imbio.2015.10.002. View

3.
Funk N, Wieghofer P, Grimm S, Schaefer R, Buhring H, Gasser T . Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson's disease. Mov Disord. 2013; 28(3):392-5. DOI: 10.1002/mds.25300. View

4.
Shin E, Cho S, Lee D, Hur M, Paik S, Park J . Expression patterns of alpha-synuclein in human hematopoietic cells and in Drosophila at different developmental stages. Mol Cells. 2000; 10(1):65-70. DOI: 10.1007/s10059-000-0065-x. View

5.
Pietras E . Inflammation: a key regulator of hematopoietic stem cell fate in health and disease. Blood. 2017; 130(15):1693-1698. PMC: 5639485. DOI: 10.1182/blood-2017-06-780882. View